Related Experiment Video
Updated: Jul 15, 2026
Extraction of Plant-based Capsules for Microencapsulation Applications
Published on: November 9, 2016
Assessing the Efficacy of Garlic Pearls Combined with Lycopene Capsules on Mouth Opening in Oral Submucous Fibrosis
Ishmita Jain1, Vikas Singh1, Ankita Jain1
1Department of Public Health Dentistry, Teerthanker Mahaveer Dental College and Research Centre, Moradabad, Uttar Pradesh, India.
Background And Aim:
Oral submucous fibrosis (OSMF) is a debilitating premalignant condition affecting individuals across all age groups and both sexes. It is particularly prevalent in India and the South Asian subcontinent. Common clinical symptoms include reduced mouth opening and a burning sensation in the oral cavity.
Materials And Methods:
Study Design: Interventional Study Setting and Sample: This study was conducted at the outpatient department (OPD) of dental clinics and included patients clinically diagnosed with OSMF. A divider and scale were used to measure interincisal mouth opening at baseline and during follow-up intervals.
Results:
Intragroup comparisons revealed a statistically significant improvement in mouth opening over the 45-day treatment period. Improvement from Day 1 to Day 15 was significant (P = 0.002), with continued progress from Day 15 to Day 30 (P = 0.003), and from Day 30 to Day 45 (P = 0.011). These findings suggest that the combination of lycopene and garlic was effective in enhancing mouth opening in OSMF patients over time.
Conclusion:
The study demonstrated a significant improvement in mouth opening among OSMF patients treated with a 45-day regimen of lycopene capsules and garlic pearls. These findings highlight the therapeutic potential of this antioxidant-based combination in the management of OSMF.
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:26Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications